Advertisement
Singapore markets closed
  • Straits Times Index

    3,313.48
    +8.49 (+0.26%)
     
  • Nikkei

    38,787.38
    -132.88 (-0.34%)
     
  • Hang Seng

    19,553.61
    +177.08 (+0.91%)
     
  • FTSE 100

    8,420.26
    -18.39 (-0.22%)
     
  • Bitcoin USD

    66,877.47
    +1,502.91 (+2.30%)
     
  • CMC Crypto 200

    1,350.62
    -23.22 (-1.67%)
     
  • S&P 500

    5,303.27
    +6.17 (+0.12%)
     
  • Dow

    40,003.59
    +134.21 (+0.34%)
     
  • Nasdaq

    16,685.97
    -12.35 (-0.07%)
     
  • Gold

    2,419.80
    +34.30 (+1.44%)
     
  • Crude Oil

    80.00
    +0.77 (+0.97%)
     
  • 10-Yr Bond

    4.4200
    +0.0430 (+0.98%)
     
  • FTSE Bursa Malaysia

    1,616.62
    +5.51 (+0.34%)
     
  • Jakarta Composite Index

    7,317.24
    +70.54 (+0.97%)
     
  • PSE Index

    6,618.69
    -9.51 (-0.14%)
     

RE/MAX (RMAX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

RE/MAX (RMAX) reported $78.29 million in revenue for the quarter ended March 2024, representing a year-over-year decline of 8.3%. EPS of $0.20 for the same period compares to $0.26 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $78.14 million, representing a surprise of +0.19%. The company delivered an EPS surprise of +17.65%, with the consensus EPS estimate being $0.17.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how RE/MAX performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Agent Count - Outside U.S. and Canada Total: 64,332 versus the two-analyst average estimate of 65,268.

  • Agent Count - Total: 143,287 versus the two-analyst average estimate of 143,990.

  • Agent Count - U.S. Total: 53,919 versus 53,638 estimated by two analysts on average.

  • Agent Count - Canada - Independent Rregions: 4,885 versus the two-analyst average estimate of 4,944.

  • Agent Count - U.S. - Company-Owned Regions: 47,302 versus the two-analyst average estimate of 47,113.

  • Agent Count - U.S. - Independent Rregions: 6,617 compared to the 6,525 average estimate based on two analysts.

  • Agent Count - Canada - Company-Owned Regions: 20,151 versus the two-analyst average estimate of 20,140.

  • Revenue- Marketing Funds fees: $20.21 million versus $19.93 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -5.3% change.

  • Revenue- Continuing franchise fees: $31.09 million compared to the $30.61 million average estimate based on three analysts. The reported number represents a change of -3.1% year over year.

  • Revenue- Franchise sales and other revenue: $8.06 million versus the three-analyst average estimate of $8.87 million. The reported number represents a year-over-year change of -35.4%.

  • Revenue- Broker fees: $10.72 million compared to the $10.34 million average estimate based on three analysts. The reported number represents a change of -1.6% year over year.

  • Revenue- Annual dues: $8.23 million versus $8.39 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -4.6% change.

View all Key Company Metrics for RE/MAX here>>>

Shares of RE/MAX have returned -12.5% over the past month versus the Zacks S&P 500 composite's -4.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RE/MAX Holdings, Inc. (RMAX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research